The landscape of Medicare is undergoing a transformative change, driven by the Inflation Reduction Act of 2022 and the Centers...
In the ever-evolving landscape of American healthcare, one issue remains a constant concern for patients, providers, payers, and policymakers alike—the...
While spending on oncology drugs in the U.S. is anticipated to reach $125 billion by 2027, overall drug savings of...
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a...